NCBiotech News

Two whopping life sciences “gets” helped put North Carolina in a special award status in the current issue of Area Development, a quarterly publication covering site selection, facility planning, and economic development.

Biotalys’ new biofungicide Evoca has received the World BioProtection Award for Best Biofungicide.

Wilmington-based Renaissance Fiber will represent the state’s southeastern region at the North Carolina Biotechnology Center’s Venture Pitch Showcase at Triad BioNight in High Point next month.

To comply with regulatory requriments under the Transparency in Coverage Rule issued by the U.S. Department of Health & Human Services, U.S. Department of Labor and U.S. Department of the Treasury, NCBiotech is disclosing transparent pricing information for health care services.

TARGAN, a Morrisville biotech startup that is focused on revolutionizing current vaccination methods for the commercial poultry industry, has landed an additional $35 million in funding.

Morrisville gene editing startup Locus Biosciences is another step closer to actualizing its biotherapeutics against bacterial diseases after landing $35 million in additional capital.

Labcorp’s new at-home collection kit is a threefer. It simultaneously tests for COVID-19, respiratory syncytial virus (RSV) and the flu, too.

When the pandemic caused Frankie Spinks to lose her job, she found a new career opportunity in biomanufacturing through the BioWork certificate program at Central Carolina Community College.

The keynote speaker, co-chairs, events team and awards committee have been selected for the June 23 Triad BioNight 2022.

Durham's Kriya Therapeutics just added $270 million to its coffers, bringing its total raised to date to roughly $450 million for novel gene therapies

AgBiome is turning to an Ohio startup, 3Bar Biologics, to partner on 3Bar's biologics delivery system that essentially brings a key part of the laboratory to the farm field.

RTP-based ag tech company Vestaron is gaining market traction with its peptide biopesticide, and has raised $82 million in financing to support commercialization of its current product lineup and fuel the R&D of new products.

North Carolina has scored top honors for its recruitment efforts for the second year in a row, landing Site Selection magazine’s 2021 Prosperity Cup,

A new industrial consortium led by the North Carolina Biotechnology Center will develop apprenticeships in the life sciences to strengthen workforce preparedness.

Durham-based Humacyte is providing engineered blood vessels to multiple hospitals in Ukraine for treating wounded civilians and soldiers with vascular injuries suffered in the Russian invasion.